Originally published In Press as doi:10.1074/jbc.M505019200 on June 24, 2005
J. Biol. Chem., Vol. 280, Issue 33, 29604-29611, August 19, 2005
Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication*
Sarah Welbourn
,
Robin Green
,
Isabelle Gamache
,
Serge Dandache
,
Volker Lohmann¶,
Ralf Bartenschlager¶,
Karen Meerovitch
, and
Arnim Pause, Recipient of a Canada Research Chair in Molecular Oncology
||
From the
McGill Cancer Center and Department of Biochemistry, McGill University, Montreal, Quebec H3G1Y6, Canada and the ¶Department Molecular Virology, University Heidelberg, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany
The hepatitis C virus NS2/3 protease is responsible for cleavage of the viral polyprotein between nonstructural proteins NS2 and NS3. We show here that mutation of three highly conserved residues in NS2 (His952, Glu972, and Cys993) abrogates NS2/3 protease activity and that introduction of any of these mutations into subgenomic NS2-5B replicons results in complete inactivation of NS2/3 processing and RNA replication in both stable and transient replication assays. The effect of uncleaved NS2 on the various activities of NS3 was therefore explored. Unprocessed NS2 had no significant effect on the in vitro ATPase and helicase activities of NS3, whereas immunoprecipitation experiments demonstrated a decreased affinity of NS4A for uncleaved NS2/3 as compared with NS3. This subsequently resulted in reduced kinetics in an in vitro NS3 protease assay with the unprocessed NS2/3 protein. Interestingly, NS3 was still capable of efficient processing of the polyprotein expressed from a subgenomic replicon in Huh-7 cells in the presence of uncleaved NS2. Notably, we show that fusion with NS2 leads to the rapid degradation of NS3, whose activity is essential for RNA replication. Finally, we demonstrate that uncleaved NS2/3 degradation can be prevented by the addition of a proteasome inhibitor. We therefore propose that NS2/3 processing is a critical step in the viral life cycle and is required to permit the accumulation of sufficient NS3 for RNA replication to occur. The regulation of NS2/3 cleavage could constitute a novel mechanism of switching between viral RNA replication and other processes of the hepatitis C virus life cycle.
Received for publication, May 6, 2005
, and in revised form, June 22, 2005.
* This work was supported in part by Grant EOP62492from the Canadian Institutes of Health Research (to A. P.) and by startup funds from the McGill Cancer Centre. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Fonds de la Recherche en Santé du Québec fellowship (Masters) and a McGill-Canadian Institutes of Health Research chemical biology training grant.
|| To whom correspondence should be addressed: McGill Cancer Center and Dept. of Biochemistry, McIntyre Bldg., Rm. 716, McGill University, 3655 Sir William Osler Promenade, Montreal, Quebec H3G 1Y6, Canada. Tel.: 514-398-1521; Fax: 514-398-3380; E-mail: arnim.pause{at}mcgill.ca.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Ma, J. Yates, Y. Liang, S. M. Lemon, and M. Yi
NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly
J. Virol.,
August 1, 2008;
82(15):
7624 - 7639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Huang, D. A. Goff, Q. Huang, A. Martinez, X. Xu, S. Crowder, S. D. Issakani, E. Anderson, N. Sheng, P. Achacoso, et al.
Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication
Antimicrob. Agents Chemother.,
April 1, 2008;
52(4):
1419 - 1429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Jones, C. L. Murray, D. K. Eastman, J. Tassello, and C. M. Rice
Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus
J. Virol.,
August 15, 2007;
81(16):
8374 - 8383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yi, Y. Ma, J. Yates, and S. M. Lemon
Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus
J. Virol.,
January 15, 2007;
81(2):
629 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis, E. Steinmann, K. Abid, F. Negro, M. Dreux, F.-L. Cosset, et al.
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
PNAS,
May 9, 2006;
103(19):
7408 - 7413.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.